GEN Exclusives

More »

GEN News Highlights

Back to Item »

Champions Biotechnology Gains Rights to Ramot’s Preclinical Anticancer Agent

TAR-1, a single-chain antibody fragment, will be evaluated on the firm’s Biomerk Tumorgraft platform.

Forward this item to a colleague:


(Separate multiple addresses by commas)


(Separate multiple addresses by commas)


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

NIH Budget Woes

Do you think that budget problems are going to lead to a growing exodus of talented researchers and administrators from the NIH?

More »